Schwab Charles Investment Management Inc. raised its position in Teladoc Inc (NYSE:TDOC) by 8.1% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 294,698 shares of the health services provider’s stock after buying an additional 22,200 shares during the period. Schwab Charles Investment Management Inc. owned about 0.42% of Teladoc worth $17,108,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently bought and sold shares of the stock. JPMorgan Chase & Co. boosted its holdings in Teladoc by 1.4% in the 1st quarter. JPMorgan Chase & Co. now owns 4,678,836 shares of the health services provider’s stock worth $188,559,000 after buying an additional 65,383 shares during the last quarter. Bamco Inc. NY boosted its holdings in Teladoc by 0.3% in the 1st quarter. Bamco Inc. NY now owns 1,938,000 shares of the health services provider’s stock worth $78,101,000 after buying an additional 6,500 shares during the last quarter. Zevenbergen Capital Investments LLC boosted its holdings in Teladoc by 1.8% in the 1st quarter. Zevenbergen Capital Investments LLC now owns 1,567,845 shares of the health services provider’s stock worth $63,184,000 after buying an additional 28,205 shares during the last quarter. Gilder Gagnon Howe & Co. LLC boosted its holdings in Teladoc by 6.0% in the 2nd quarter. Gilder Gagnon Howe & Co. LLC now owns 1,477,276 shares of the health services provider’s stock worth $85,756,000 after buying an additional 83,319 shares during the last quarter. Finally, Champlain Investment Partners LLC boosted its holdings in Teladoc by 8.2% in the 1st quarter. Champlain Investment Partners LLC now owns 909,110 shares of the health services provider’s stock worth $36,637,000 after buying an additional 68,655 shares during the last quarter.
In related news, VP Mark Hirschhorn sold 20,000 shares of the company’s stock in a transaction that occurred on Tuesday, July 10th. The stock was sold at an average price of $63.00, for a total value of $1,260,000.00. Following the transaction, the vice president now directly owns 2,791 shares in the company, valued at $175,833. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Adam C. Vandervoort sold 5,550 shares of the company’s stock in a transaction that occurred on Monday, September 10th. The shares were sold at an average price of $77.67, for a total value of $431,068.50. Following the completion of the transaction, the insider now owns 2,934 shares in the company, valued at $227,883.78. The disclosure for this sale can be found here. Insiders sold 242,497 shares of company stock worth $16,108,269 over the last quarter. 3.95% of the stock is currently owned by insiders.
Several research analysts have recently weighed in on TDOC shares. KeyCorp boosted their target price on Teladoc from $74.00 to $90.00 and gave the stock an “overweight” rating in a report on Monday, August 27th. TheStreet upgraded Teladoc from a “d+” rating to a “c” rating in a report on Wednesday, August 22nd. Leerink Swann started coverage on Teladoc in a report on Thursday, August 16th. They set an “outperform” rating and a $90.00 target price on the stock. SunTrust Banks boosted their target price on Teladoc to $77.00 and gave the stock a “buy” rating in a report on Thursday, August 9th. Finally, Chardan Capital boosted their target price on Teladoc from $73.00 to $86.00 and gave the stock a “buy” rating in a report on Friday, August 3rd. One research analyst has rated the stock with a sell rating, five have issued a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $65.10.
TDOC opened at $77.75 on Friday. Teladoc Inc has a one year low of $27.30 and a one year high of $79.64. The company has a debt-to-equity ratio of 0.58, a current ratio of 3.14 and a quick ratio of 3.14.
Teladoc (NYSE:TDOC) last released its quarterly earnings data on Wednesday, August 1st. The health services provider reported ($0.37) EPS for the quarter, beating analysts’ consensus estimates of ($0.38) by $0.01. Teladoc had a negative return on equity of 19.10% and a negative net margin of 37.78%. The firm had revenue of $94.60 million for the quarter, compared to analysts’ expectations of $91.56 million. During the same period in the prior year, the firm posted ($0.28) earnings per share. The firm’s quarterly revenue was up 112.1% on a year-over-year basis. analysts anticipate that Teladoc Inc will post -1.51 earnings per share for the current year.
Teladoc, Inc provides telehealth services worldwide. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.
Receive News & Ratings for Teladoc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc and related companies with MarketBeat.com's FREE daily email newsletter.